Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinnreich, M.
Right arrow Articles by Karpati, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinnreich, M.
Right arrow Articles by Karpati, G.
Related Collections
Right arrow Muscle disease
NEUROLOGY 2006;66:1114-1116
© 2006 American Academy of Neurology


Brief Communications

Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy

Michael Sinnreich, MD, Christian Therrien, PhD and George Karpati, MD

From the Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Address correspondence and reprint requests to Dr. Michael Sinnreich, Montreal Neurological Institute, Room 633, 3801 University Street, Montreal, Quebec H3A 2B4, Canada; e-mail: michael.sinnreich{at}mcgill.ca

The authors report a genotype-phenotype correlation in a limb-girdle muscular dystrophy 2B family. Two severely affected sisters were homozygous for a dysferlin null mutation. Their mildly affected compound heterozygous mother harbored, in addition to one null allele, an in-frame exon-skipping allele caused by a novel lariat branch point mutation. The dysferlin molecule arising from the latter allele appeared to partially complement the null mutation, likely accounting for the mother's mild phenotype.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the April 11 issue to find the title link for this article.

This study was supported by grants from the Association Française contre les Myopathies, the Neuromuscular Research Partnership of the Canadian Institutes of Health Research, the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada, and the Fonds de Recherche en Santé Quebec.

Disclosure: The authors report no conflicts of interest.

Received October 25, 2005. Accepted in final form December 29, 2005.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
F.-O. Desmet, D. Hamroun, M. Lalande, G. Collod-Beroud, M. Claustres, and C. Beroud
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Nucleic Acids Res., May 1, 2009; 37(9): e67 - e67.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Illa, N. De Luna, R. Dominguez-Perles, R. Rojas-Garcia, C. Paradas, J. Palmer, C. Marquez, P. Gallano, and E. Gallardo
Symptomatic dysferlin gene mutation carriers: Characterization of two cases
Neurology, April 17, 2007; 68(16): 1284 - 1289.
[Abstract] [Full Text] [PDF]